The frequency of events targeting p53 (del 17p, TP53 mutation or double hits) increases during the progression of MM and consecutive relapses underlining a selection of cells harboring TP53 abnormalities in association with resistance to treatment. The gene discussed is TP53; the disease is Miyoshi myopathy.